Herpes Simplex Virus 2 News and Research

RSS
Herpes Simplex Virus-2 is a sexually transmitted viral infection, which often produces painful sores, usually in the genital area. Once infected, an individual may carry the virus and be subject to recurrent bouts of infection. Some estimate that as many as 20 percent of the adult population in the United States has been exposed to the virus.
Maternal antiviral suppressive therapy may not be as effective as thought

Maternal antiviral suppressive therapy may not be as effective as thought

Scientists discover tumor-targeting neural stem cells

Scientists discover tumor-targeting neural stem cells

Allied Healthcare announces Coridon license to vector technology

Allied Healthcare announces Coridon license to vector technology

Abbott receives CE Marking for PLEX-ID instrument and assays

Abbott receives CE Marking for PLEX-ID instrument and assays

Study reveals how HSV-1 virus overcomes intrinsic host defenses

Study reveals how HSV-1 virus overcomes intrinsic host defenses

Common sexually transmitted bacterial infection more than doubles risk of HIV

Common sexually transmitted bacterial infection more than doubles risk of HIV

Infection with M. genitalium may double African women's HIV risk

Infection with M. genitalium may double African women's HIV risk

Investigational HSV vaccine shows promise against two genital herpes diseases

Investigational HSV vaccine shows promise against two genital herpes diseases

Researchers identify first gene associated with frequent herpes-related cold sores

Researchers identify first gene associated with frequent herpes-related cold sores

Researchers to begin drug development projects for rare and neglected diseases

Researchers to begin drug development projects for rare and neglected diseases

NCI awards UAB $2.3M brain-tumor SPORE grant

NCI awards UAB $2.3M brain-tumor SPORE grant

C21orf91 gene associated with susceptibility to herpes simplex labialis

C21orf91 gene associated with susceptibility to herpes simplex labialis

Tenofovir gel shows promise against HSV infection

Tenofovir gel shows promise against HSV infection

HSV1 drugs could slow progression of Alzheimer's disease

HSV1 drugs could slow progression of Alzheimer's disease

FDA clears BioHelix IsoAmp HSV molecular diagnostic assay

FDA clears BioHelix IsoAmp HSV molecular diagnostic assay

USAID award supports study of SILCS diaphragm plus tenofovir gel on HIV, HSV

USAID award supports study of SILCS diaphragm plus tenofovir gel on HIV, HSV

Coridon demonstrates 100% protection using DNA HSV-2 vaccine

Coridon demonstrates 100% protection using DNA HSV-2 vaccine

Isconova expands Matrix M collaboration with Genocea to treat infectious diseases

Isconova expands Matrix M collaboration with Genocea to treat infectious diseases

DNA vaccine developer Coridon in U.S. collaboration

DNA vaccine developer Coridon in U.S. collaboration

New 3D herpes infection model brings hope

New 3D herpes infection model brings hope